baber/WOPTO huggingface dataset:
Patent AU-730772-B2 (AU)
Title: Aqueous dispersion based on silicones and on organic (co) polymer latex, for the preparation of a silicone elastomer with adjustable translucency
Inventor: ALLEST JEAN-FRANCOIS D
IPC: C09D5/34
Filed: 1996-06-12
Granted: 2001-03-15
Abstract: The invention discloses a silicon and organic (co)polymer latex based aqueous dispersion, cross-linking by eliminating water through drying in ambient conditions into an elastomer with adjustable translucency having high mechanical properties, characterised in that it is not provided with any reinforcing mineral filler and in that it comprises the following constituents: (A) an oil-in-water emulsion with 100 parts by weight of an oil or a polymer  alpha ,  omega -(dihydroxy)polydiorganosiloxane (A1) and 1 to 100 parts by weight of an organosilicic cross-linking agent (A2), the said emulsion being stabilised by at least one surfactant (A3) selected among anionic and non-ionic surfactants and their mixtures; and with a particle size between 0.1  mu m (100 nm) and 100  mu m (100000 nm); and having a dry extract content of at least 60 wt.%; (B) for 100 parts by weight of oil or polymer (A1), 1 to 100 parts by weight of an aqueous dispersion of at least an organic (co)polymer with a particle size of 0.01  mu m (10 nm) to 10  mu m (10000 nm), and a dry extract of 10 to 70 wt.%; (C) optionally, for 100 parts by weight of oil or polymer (A1), 0.01 to 5 parts by weight of a hardening catalytic metal compound. The dispersions are useful in producing translucid silicon elastomers for the building industry.
Patent AU-590803-B2 (AU)
Title: Solar cell
Inventor: HEZEL RUDOLF
IPC: H01L31/02
Filed: 1986-10-08
Granted: 1989-11-16
Abstract: PCT No. PCT/EP86/00573 Sec. 371 Date Jun. 10, 1987 Sec. 102(e) Date Jun. 10, 1987 PCT Filed Oct. 8, 1986 PCT Pub. No. WO87/02513 PCT Pub. Date Apr. 23, 1987.A solar cell (10), preferably of silicon, having a semiconductive substrate (1) on one side of which an electrical field is provided by, for example, an MIS contact (1, 2, 3) to cause a separation of charge carriers generated by light energy. The minority charge carriers are drawn into the metal (3) of the MIS contact, whereas the majority charge carriers are discharged via ohmic contact zones (4) arranged on the opposite side of the semiconductive substrate. At least one passivation layer (5) is arranged on the semiconductive substrate between the ohmic contact zones, whereby the recombination velocity of the charge carriers in the area of the ohmic contact zones is considerably reduced.
Patent AU-746819-B2 (AU)
Title: Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies
Inventor: HSEI VANESSA
IPC: A61K47/48
Filed: 1998-02-20
Granted: 2002-05-02
Abstract: (A) A conjugate consisting of one or more antibody fragments covalently attached to one or more non-proteinaceous polymer molecules (NPPMs), where the apparent size of the conjugate is at least 500 kD.Also claimed are: (B) a conjugate formed by one or more antibody fragments covalently attached to one or more NPPMs, where the apparent size of the conjugate is at least 500 kD and where the molecular structure of the conjugate is free of other matter; (C) a conjugate formed by one or more antibody fragments covalently attached to one or more NPPMs, where the apparent size of the conjugate is at least 500 kD, where the antibody fragment incorporates a nonproteinaceous label free of any polymer, and where the molecular structure of the conjugate is free of other matter; (D) a polypeptide selected from a polypeptide that is an anti-IL-8 monoclonal antibody (MAb) or antibody fragment comprising a light chain amino acid sequence comprising the complementarity determining regions (CDRs) of the light chain polypeptide amino acid sequence shown; (E) a nucleic acid molecule that comprises a nucleic acid sequence encoding a polypeptide as in (D); (F) an expression vector comprising a nucleic acid molecule as in (E) operably linked to control sequences recognised by a host cell transfected with the vector; (G) a host cell comprising a vector as in (F).
Patent AU-648997-B2 (AU)
Title: Osteogenic devices
Inventor: OPPERMANN HERMANN
IPC: C07K14/51
Filed: 1990-10-15
Granted: 1994-05-12
Abstract: Disclosed are 1) amino acid sequence data, structural features, and various other data characterizing a human osteogenic protein, OP1, 2) osteogenic devices comprising a heat treated xenogenic bone collagen matrix containing osteogenic protein, 3) methods of producing osteogenic proteins using recombinant DNA technology and 4) use of osteogenic devices to mimic the natural course of endochondral bone formation in mammals.
Patent AU-625017-B2 (AU)
Title: Biosensors
Inventor: GITLER CARLOS
IPC: G01N27/416
Filed: 1991-01-09
Granted: 1992-06-25
Abstract: Biosensors for qualitative and quantitative analysis comprise an amphipathic liquid crystalline membrane composed of a lipid bilayer attached to a recording electrode via bridging anchoring molecules. The lipid bilayer is doped with biologic or synthetic ion channels and is in continuous contact with a bulk aqueous medium on both its surfaces. The bridging anchoring molecules may contain a phospholipid moiety linked to a polyoxyalkylene chain terminated with a thiol or thioether residue. <IMAGE>
Patent AU-583982-B2 (AU)
Title: A process for recovering sulfur from sulfur-containing gases
Inventor: LAGAS JAN ADOLF
IPC: B01J35/10
Filed: 1987-04-14
Granted: 1989-05-11
Abstract: The invention is directed to a process for the recovery of sulfur from a hydrogen sulfide containing gas, which comprises oxidizing hydrogen sulfide with oxygen, and then reacting the product gas of this oxidation further by using at least two catalytic stages, in accordance with the equation: 2H2S + SO2 2H2O + 3/n Sn. In order to improve the process and the process control, the invention is characterized in that the H2S concentration in the gas leaving the last catalytic stage (17) is controled (23) to have a value ranging between 0.8 and 3% by volume by reducing the quantitiy of combustion or oxidation air passed to the oxidation stage (2) and/or causing a portion of the hydrogen sulfide containing feedstock gas to bypass (25) the oxidation stage and to be added to the gas flowing to a catalytic stage.
Patent AU-689789-B2 (AU)
Title: Methods for enhancing nucleic acid amplification
Inventor: RYDER THOMAS B
IPC: C12Q1/6865
Filed: 1994-07-20
Granted: 1998-04-09
Abstract: A method for amplification of a nucleic acid strand in a test sample. The method includes contacting the nucleic acid strand from the test sample simultaneously with at least three oligonucleotide primers. At least one primer is a promoter-primer, and at least one other primer is complementary to the nucleic acid strand, and one other primer is complementary to a strand complementary to the nucleic acid strand. The method further includes contacting the nucleic acid strand and primers with one or more proteins having RNA-directed and/or DNA-directed DNA polymerase activities, an RNA polymerase activity, and an RNAse H activity under primer-extension conditions to allow amplification of a target region in the nucleic acid strand at essentially constant temperature. <IMAGE>
Patent AU-609720-B2 (AU)
Title: Fused imidazoheterocyclic compounds
Inventor: TOMCZUK BRUCE EDWARD
IPC: C07D405/12
Filed: 1987-06-04
Granted: 1991-05-09
Abstract: Imidazoheterocyclic compounds having the formula: <CHEM> wherein A is a pyridine ring in any of its four positions; B is carbonyl, thioxomethyl or hydroxymethylene; Z is hydrogen, halogen, loweralkyl, hydroxy, loweralkoxy, diloweralkylamino or nitro; Ar is phenyl, pyrido, thienyl or furanyl; and W forms a wide combination of groups with B, including acids, esters, alcohols, amides and ketones. The compounds have CNS activity and find use as muscle relaxants, anticonvulsants and antianxiety agents.
Patent AU-632676-B2 (AU)
Title: Preparation of optically active norbornane amine derivatives
IPC: C07C229/32
Filed: 1991-03-27
Granted: 1993-01-07
Abstract: A process for preparing an optically active compound useful as an intermediate for the preparation of clinically important thromboxane A2 (TXA2) receptor antagonist by resolving a racemic mixture of norbornyl amine of formula (I): <CHEM> wherein R<1> is hydrogen, lower alkyl or lower alkyl substituted with -COOR<3> at the terminal methyl residue; R<3> is lower alkyl; Y is oxygen or methylene; m and n are independently 0 or 1 with a chiral acid.
Patent AU-600950-B2 (AU)
Title: Controlled release dihydrocodeine composition
Inventor: GOLDIE ROBERT STRONECH
IPC: A61K9/20
Filed: 1987-06-10
Granted: 1990-08-30
Abstract: A solid controlled release, oral dosage form, the dosage form comprising an analgesically effective amount of dihydrocodeine or a salt thereof in a controlled release matrix wherein the dissolution rate in vitro of the dosage form, when measured by the USP Paddle Method at 100 rpm in 900 ml aqueous buffer (pH between 1.6 and 7.2) at 37 DEG C is between 25% and 60% (by weight) dihydrocodeine released after 1 hour, between 45% and 80% (by weight) dihydrocodeine released after 2 hours, between 60% and 90% (by weight) dihydrocodeine released after 3 hours and between 70% and 100% (by weight) dihydrocodeine released after 4 hours, the in vitro release rate being independent of pH between pH 1.6 and 7.2 and chosen such that the peak plasma level of dihydrocodeine obtained in vivo occurs between 2 and 4 hours after administration of the dosage form.
Patent AU-678284-B2 (AU)
Title: Nickel-free phosphatization process
Inventor: ROLAND WOLF-ACHIM
IPC: C23C22/12
Filed: 1994-08-29
Granted: 1997-05-22
Abstract: PCT No. PCT/EP94/02848 Sec. 371 Date Mar. 6, 1996 Sec. 102(e) Date Mar. 6, 1996 PCT Filed Aug. 29, 1994 PCT Pub. No. WO95/07370 PCT Pub. Date Mar. 16, 1995A process for phosphating surfaces of steel, galvanized or alloy-galvanized steel, aluminum, aluminized or alloy-aluminized steel. The process is particularly useful for treating metal surfaces which are to be cathodic electrocoated. The process uses a nickel, cobalt, copper, nitrite and oxo-anion of halogen free phosphating solution containing 0.3 to 2.0 g/l Zn(II), 0.3 to 4 g/l Mn(II), 5 to 40 g/l phosphate ions and at least one of 0.5 to 5 g/l hydroxylamine and 0.2 to 2 g/l m-nitrobenzene sulfonate wherein the ratio by weight of Zn(II) to Mn(II) is not greater than 2.
Patent AU-660609-B2 (AU)
Title: Azacyclic or azabicyclic compounds, their preparation and use
Inventor: WARD JOHN S
IPC: C07D471/08
Filed: 1991-03-20
Granted: 1995-07-06
Abstract: The present invention relates to therapeutically active azacyclic or azabicyclic compounds, a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful as stimulants of the cognitive function of the forebrain and hippocampus of mammals and especially in the treatment of Alzheimer's disease.
Patent AU-770137-B2 (AU)
Title: Table with pivotable table-top
Inventor: THODE JURGEN
IPC: A47B3/00
Filed: 2000-08-22
Granted: 2004-02-12
Abstract: A table with a pivotable table top for changing between a working position and a stacking position. The table has a table top and a table frame, wherein the table frame has a horizontal beam, at least one support part for supporting the table top and one or more table legs fixedly coupled to the support part, wherein the table top is hinged to the table frame so as to be pivotable about a horizontal pivot axis, and wherein the support part is movable transversely with respect to the pivot axis between the working position and the stacking position or is coupled to the beam so as to be pivotable about a vertical axis. Between the table top and the support part coupling means are provided which effect common pivoting or turning of the table top and of the table leg coupled to the support part.
Patent AU-656722-B2 (AU)
Title: Apparatus and method for sedimentation based blood analysis
Inventor: MCKINNEY DAVID K
IPC: G01N15/05
Filed: 1991-04-17
Granted: 1995-02-16
Abstract: An apparatus and process for accurately determining settling data for the settling of erythrocyte cells from a plasma fluid in a test specimen of blood. The apparatus includes a settling tube, a sensing assembly movably mounted proximate the settling tube. Preferably an infrared emitter and detector are provided in the sensing assembly, and a control assembly is provided which senses data at a high rate and is responsive to the sensed data to sample or store the time at which sensed reflectivity exceeds a threshold level. When the threshold is reached, data is sampled and the tracking head is moved by a very small step. This process is repeated to enable tracking of the descent of the separation boundary between the erythrocyte cells and plasma fluid. The apparatus senses changes in reflectivity of the erythrocyte portion of the specimen below and up to the separation boundary. The apparatus and process also includes a scanning process to calibrate the reflectivity for each test specimen, the reflectivity also is measured immediately after moving the sensing assembly and recorded as a function of the position of the sensing assembly. An apparatus and process for scanning the plasma fluid and white cells above the separation boundary for reflectivity of infrared or visible light radiation as a function of height above the separation boundary also is disclosed.
Patent AU-679573-B2 (AU)
Title: Therapeutic agents
Inventor: HEAL DAVID JOHN
IPC: A61P25/00
Filed: 1994-10-12
Granted: 1997-07-03
Abstract: PCT No. PCT/EP94/03364 Sec. 371 Date Jun. 25, 1996 Sec. 102(e) Date Jun. 25, 1996 PCT Filed Oct. 12, 1994 PCT Pub. No. WO95/10521 PCT Pub. Date Apr. 20, 1995Compounds of formula (I) which includes pharmaceutically acceptable salts thereof and stereoisomers thereof:    <IMAGE>  (I)  wherein: R1 represents H or one of the following groups (optionally substituted with one or more of halo, cyano, hydroxy or amino): C1-6 alkyl, C1-6 alkoxy or C1-6 alkanoyl; R2 and R3 independently represent H or one of the following groups (optionally substituted with one or more of halo, cyano, hydroxy or amino): C1-6 alkyl, C1-6 alkoxy or C1-6 alkanoyl, C1-6 alkylthio, C1-6 alkylsulphinyl or C1-6 alkylsulphonyl; R4 and R5 combined together with the carbon atom to which they are attached represent C3-6 cycloalkylidene (each alkyl or cycloalkylidene being optionally substituted with one or more of halo, cyano, hydroxy, amino or C1-6 alkyl); and R6, R7 and R8 independently represent H, halo, hydroxy, mercapto, cyano or one of the following groups (optionally substituted with one or more of halo, cyano, hydroxy or amino; and any nitrogen atom being optionally substituted with one or more C1-6 alkyl): C1-6 alkyl, C1-6 alkoxy or C1-6 alkanoyl, C1-6 alkylthio, C1-6 alkylsulphinyl, etc; have utility in the treatment and/or prophylaxis or seizures, neurological disorders such as epilepsy and/or conditions in which there is neurological damage such as stroke, brain trauma, head injuries and haemorrhage.
Patent AU-677116-B2 (AU)
Title: Use of organofunctionally modified polysiloxanes for defoaming diesel fuel
Inventor: SPIEGLER ROLAND
IPC: C08G77/46
Filed: 1994-12-19
Granted: 1997-04-10
Abstract: A method of defoaming diesel fuel by adding an organofunctionally modified polysiloxane of the general Formula I   <IMAGE>   wherein R1are alkyl groups with 1 to 4 carbon atoms or aryl groups with the proviso that at least 80% of the R1groups are methyl groups, R2 are the same or different in the molecule 30 to 90% of R2 having the same meaning as R1, and 70 to 10% of R2 consisting of a mixture of R2A and R2B groups which differ in polarity, is described. The inventive polysiloxane is added in an amount of 0.5 to 50 ppm, based on the diesel fuel.
Patent AU-770634-B2 (AU)
Title: Method and apparatus for the production of purified plasma proteins
Inventor: SHANBROM EDWARD
IPC: C07K1/18
Filed: 1998-06-23
Granted: 2004-02-26
Abstract: Enhanced production of cryoprecipitate is produced by dehydrating an individual unit of plasma prior to a low temperature step used to produce cryoprecipitate. This dehydration is accomplished either by placing a water absorbing material within a blood bag so that plasma occupying the bag will become dehydrated or by placing the water absorbing material within a cartridge so that plasma becomes dehydrated upon flowing through the cartridge. The preferred water-absorbing material is a cross-linked chromatographic gel having pores too small to admit clotting proteins, but large enough to admit water molecules. Suitable gels are made from carbohydrates or polyacrylamide. Carbohydrate gels such as Sephadex3, produced by Pharmacia-Upjohn, are particularly preferred in the present invention. An alternative embodiment of the invention replaces the simple water-absorbing gel with one that also has ion exchange capabilities, such as DEAE (diethy-aminoethyl) Sephadex3 which has a special affinity for a number of blood clotting factors collectively known as the prothrombin complex. Following the dehydration step the DEAE Sephadex3 is eluted to produce prothrombin complex.
Patent AU-550865-B2 (AU)
Title: Production of micro-organisms
Inventor: AMEN JEAN
IPC: C12N1/00
Filed: 1982-04-28
Granted: 1986-04-10
Abstract: This invention relates to the production of the microorganisms. The operation is conducted in two stages. The first stage is conducted in the absence of ultrafiltration while the pH of the growth medium is maintained within the range of 6-7 by the addition of a neutralizing agent. Nutrient substratum and dilution water are added during the first stage to maintain the growth rate at a constant level, and the volume of growth medium is permitted to increase. When the amount of growth inhibiting agent produced in the fermentation reaches a predetermined maximum level, the second stage is initiated and the growth rate is maintained in a range of 0.10 to 0.50/hr, which is less than the growth rate in the first stage. By increasing the amount of dilution water the concentration of the growth inhibiting agent is maintained so as to achieve the desired moderate growth rate. The growth inhibiting agent is also continuously removed from the growth medium during the second stage and the volume of the growth medium is maintained substantially constant. The invention may be applied to the production of lactic bacteria, in particular for example in the cheese and wine making industries.
Patent AU-550391-B2 (AU)
Title: Derivatives of c-076 compounds
Inventor: BUHS RUDOLF P
IPC: C12P19/62
Filed: 1982-05-05
Granted: 1986-03-20
Abstract: Certain new derivatives of C-076 compounds have been isolated from the livers of animals that had been administered ivermectin and the in vitro incubation of such compounds with animal liver preparations. The compounds have the formula: 
<CHEM>
 in which R1 is 
<CHEM>
 R2 is methyl or ethyl and the 22,23 bond is saturated or (but only when R2 is ethyl) ethylenically unsaturated, or R is hydrogen, R2 is methyl or ethyl and the 22,23 bond is saturated. 
<??>The new compounds have been found to retain the biological activity of the parent C-076 compounds. The compounds are thus potent antiparasitic agents and compositions and methods for such uses are also disclosed.
Patent AU-751992-B2 (AU)
Title: Installation for packaging products in containers closed with a cork and device for dynamic storage of corks used therein
Inventor: DEROUAULT PHILIPPE
IPC: B29C49/28
Filed: 1998-07-01
Granted: 2002-09-05
Abstract: An installation for the packaging of a product in containers closed with a stopper, including in particular a filling machine (1), a stopping machine (3) and, upstream of this, a device (6) for the dynamic storage of stoppers suitable to drive the stoppers continuously and with a pre-specified pitch, the number of stoppers present simultaneously in the device (6) being at least equal to that of the containers present in a pre-specified part (7) of the installation, means (8) for the control of the supply of stoppers being provided upstream of the device (6) to control a device (10) for supplying containers located upstream of the pre-specified part (7); thus, for every container engaged in the pre-specified part (7) corresponds a stopper present in the device (6) supplying the stopping machine (3) and, in the event of an incident in the supply of stoppers upstream of the device (6), the supply of containers from the pre-specified part (7) is controlled (9, 10) while maintaining the operation of the terminal part of the installation at least until the incident is over.
Patent AU-663062-B2 (AU)
Title: Method of assay
Inventor: ATTRIDGE JOHN WORTHINGTON
IPC: G01N33/543
Filed: 1991-11-21
Granted: 1995-09-28
Abstract: A method of assay for a ligand in a sample is described in which calibration occurs within the assay. This is achieved utilising a measurement region and one or more calibration regions. In at least one of the calibration regions a non-zero signal results, either because of the presence of a calibration reagent or as a result of a binding reaction analagous to that which takes place in the measurement region.
Patent DE-1953077-B2 (DE)
Title: Combined gas, electric and liquid supply terminal - has electric connections in front two channels of support rail and rest in rear channel
IPC: H02G3/12
Filed: 1969-10-22
Abstract: The combined terminal is used in hospitals and laboratories, and it has a single support rail containing the channels for the various systems supply lines and the connectors for connecting to them. The support tails are divided by semi-partition walls into three channels: one of the channels at the rear is used to carry the supply lines for all three services, and there are two channels at the front behind the cover plate. The connections for the liquid, gas and vacuum systems are located in the rear channel, whilst the connections for the electrical system are located in the front two channels.
Patent DE-2104440-B2 (DE)
Title: Bag stacking - using accelerating unit for bag end to clear high-speed supply conveyor
IPC: B65H29/68
Filed: 1971-01-30
Abstract: Designed to handle sacks and/or bags of plastics film, the bags are fed by a high-speed conveyor, to match the high output of bag prodn. At the end of the conveyor the bag is grasped by grips on a slower-moving conveyor, and the end of the bag is accelerated to clear it before the next bag is grasped. The bag forms a loop, its end trailing along a plate until the grips open to deposit it in a stack in a magazine.
Patent DE-2207565-B2 (DE)
Title: Anti-roll stabilising tanks for ship - with smaller tanks positioned over each other and beside each other
IPC: B63B39/03
Filed: 1972-02-18
Abstract: The ship is stabilised for roll by a system of fluid filled tanks arranged at different levels and divided by bulkheads into tank sections. The air spaces above the tanks are joined by control valves to regulate the flow of fluid as the ship rolls. The air spaces of different layers are joined by another set of air lines so that the roll frequency of the ship canbe altered w.r.t. wave conditions. The system is readily trimmed for all types of seas and all types of loading without complicated re-ballasting.
Patent DE-2214598-B2 (DE)
Title: Table-top microfiche reader and copier - has pivoted mirror to select copying or viewing position as required
IPC: G03B21/11
Filed: 1972-03-25
Abstract: The microfilm copier/viewer occupies a compact, table top housing with a horizontal slot near the bottom front to locate the microfilm. A compact projection system projects the image onto a mirror which is pivoted about a transverse axis intersected by the middle axis of the optical system. The mirror is set in one of two positions by a simple hand control on the side of the housing, to project the image either to a copying position on the back wall of the housing, or onto a viewing screen on the top front of the housing. Another mirror is set at an angle in the top of the housing is used for this. The magnification of both systems is selected to be the same for simpler operation and layout.